期刊文献+

乳腺癌患者血清VEGF的表达及临床意义 被引量:14

Expression and clinical significance of serum levels of vegf in breast cancer
下载PDF
导出
摘要 目的探讨乳腺癌患者血清中血管内皮生长因子(vascular endothelial growth factor,VEGF)的表达及临床意义。方法收集乳腺癌患者146例为试验组,乳腺良性疾病患者30例为对照组,采用酶联免疫吸附测定法定量检测血清VEGF水平,分析2组血清VEGF的表达水平,比较试验组中不同临床因素(年龄、组织学分级、TNM分期、人表皮生长因子受体2、雌激素受体、孕激素受体)患者血清VEGF的表达水平。结果乳腺癌患者血清VEGF表达水平明显高于乳腺良性疾病患者,差异有统计学意义(P<0.05)。患者组织学分级越高,TNM分期越晚,人表皮生长因子受体2阳性状态,血清中VEGF的表达水平越高,差异有统计学意义(P<0.05);不同年龄、雌激素受体、孕激素受体乳腺癌患者血清VEGF的表达水平差异无统计学意义(P>0.05)。结论血清VEGF在乳腺癌患者中呈现高表达,并且与乳腺癌的进展、转移和预后有关,血清VEGF可为乳腺癌的早期诊断、靶向治疗和预后评估提供理论依据。 Objective To explore the expression and clinical significance of serum levels of vascular endothelial growth factor(VEGF)in breast cancer.Methods A total of 146 cases of breast cancer patients were selected as experimental group and 30 cases of benign breast disease as control group.Enzyme linked immunosorbent assay method was used to determine serum VEGF levels,the level of serum VEGF in the two groups was analyzed,and serum VEGF levels in patients with different clinical factors(age,histological grade,TNM staging,human epidermal growth factor receptor-2,estrogen receptor,progesterone receptor)in the experimental group were compared.Results The expression of serum VEGF in breast cancer patients was significantly higher than that in benign breast disease patients,and the difference was statistically significant(P<0.05).The higher the histological grade,the later the TNM stage,the higher the human epidermal growth factor receptor-2 positive state,the higher the serum VEGF expression level.Differences are statistically significant(P<0.05).There was no significant difference in serum VEGF expression among breast cancer patients with different ages,estrogen receptor and progesterone receptor(P>0.05).Conclusion Serum VEGF is highly expressed in breast cancer patients and is related to the progression,metastasis and prognosis of breast cancer.Serum VEGF can provide a theoretical basis for the early diagnosis,targeted therapy and prognosis evaluation of breast cancer.
作者 王美祺 张世玉 毛超丽 刘欢 宋振川 胡大为 WANG Mei-qi;ZHANG Shi-yu;MAO Chao-li;LIU Huan;SONG Zhen-chuan;HU Da-wei(Department of Breast Surgery,Affiliated Hospital of Chengde Medical College,Hebei Province,Chengde 067000,China;Department of Breast Surgery,the Forth Hospital of Heibei Medical University,Shijiazhuang 050011,China)
出处 《河北医科大学学报》 CAS 2018年第4期416-419,424,共5页 Journal of Hebei Medical University
关键词 乳腺肿瘤 血管内皮生长因子 酶联免疫吸附测定 breast neoplasms vascular endothelial growth factors enzyme-linked immunosorbent assay
  • 相关文献

参考文献8

二级参考文献89

  • 1刘晓菲,宋爱莉,李静蔚,殷玉琨.莪术油对大鼠乳腺癌癌前病变MVD及相关调控因子VEGF/FLK表达的干预作用研究[J].中医药学报,2011,39(4):19-21. 被引量:15
  • 2Bauer KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor (ER)-negative,progesterone receptor (PR)-negative,and HER2-negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California cancer Registry[J].Cancer,2007,109(9):1721-1728.
  • 3Cleator S,Heller W,Coombes RC.Triple-negative breast cancer:therapeutic options[J].Lancet Oncol,2007,8(3):235-244.
  • 4Rakha EA,El-Sayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109(1):25-32.
  • 5Haffty BG,Yang Q,Reiss M,et al.Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer[J].J Clin Oncol,2006,24(36):5652-5657.
  • 6Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clin Cancer Res,2007,13(15Pt1):4429-4434.
  • 7Shivakumar S,Prabhakar BT,Jayashree K,et al.Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density(MVD) as prognostic indicators in carcinoma breast[J].J Cancer Res Clin Oncol,2009,135 (4):627-636.
  • 8Linderholm B,Tavelin B,Grankvist K,et al.Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma[J].J Clin Oncol,1998,16(9):3121-3128.
  • 9Kowanetz M,Ferrara N.Vascular endothelial growth factor signaling pathways:therapeutic perspective[J].Clin Cancer Res,2006,12 (17):5018-5022.
  • 10Linderholm BK,Hellborg H,Johansson U,et al.Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer[J].Ann Oncol,2009,20(10):1639-1646.

共引文献84

同被引文献125

引证文献14

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部